Skip to main content

Table 6 Occurrence of adverse cardiovascular events between the different CYP2C19 genotypes and PON-1 Q192R genotypes

From: The impact of cytochrome 450 and Paraoxonase polymorphisms on clopidogrel resistance and major adverse cardiac events in coronary heart disease patients after percutaneous coronary intervention

groupGenotypeMACENON-MACEP
CYP2C19*1/*1263 
*1/*21840< 0.001
*1/*3390.025
*2/*2116< 0.001
*2/*371< 0.001
 AA(QQ)320 
PON-1AG(QR)13510.534
 GG(RR)25480.051
  1. p < 0.05 was considered significant